700
Participants
Start Date
October 7, 2021
Primary Completion Date
April 1, 2027
Study Completion Date
March 31, 2028
Seasonal influenza vaccine
The seasonal influenza vaccine is administered intramuscularly at a dose of 15 ug of HA per component, as approved by the FDA.
RECRUITING
University of Pennsylvania, Philadelphia
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Stanford University
OTHER
The Scripps Research Institute
OTHER
University of Pennsylvania
OTHER